Ahrén, B., Foley, J. E., Ferrannini, E., Matthews, D. R., Zinman, B., Dejager, S., & Fonseca, V. A. (2010). Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association.

Ahrén, Bo, James E. Foley, Ele Ferrannini, David R. Matthews, Bernard Zinman, Sylvie Dejager, and Vivian A. Fonseca. Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association, 2010.

Ahrén, Bo, et al. Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association, 2010.